This was developed by crossing H11LNL-Myc heterozygous mice with Alb-cre transgenic mice to generate Myc/Alb-cre double-positive mice that spontaneously develop HCC after 2 months due to abnormal and activated Myc43, which is frequently altered in HCC patients44. The gene discussed is ALB; the disease is hepatocellular carcinoma.